{
    "Title": "Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening",
    "URL": "https://doi.org/10.1371/journal.pntd.0001298",
    "Published": "August 30, 2011",
    "Subject_Areas": [
        "Parasitic diseases",
        "Trypanosoma cruzi",
        "Trypomastigotes",
        "Mouse models",
        "Luciferase",
        "Host cells",
        "Genetically modified animals",
        "Drug screening"
    ],
    "Authors": {
        "Grasiella Andriani": [
            "Division of Medical Parasitology, Department of Microbiology, New York University School of Medicine, New York, New York, United States of America"
        ],
        "Anne-Danielle C. Chessler": [
            "Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America"
        ],
        "Gilles Courtemanche": [
            "Infectious Diseases Unit, Sanofi-Aventis, Toulouse, France"
        ],
        "Barbara A. Burleigh": [
            "Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America"
        ],
        "Ana Rodriguez": [
            "Division of Medical Parasitology, Department of Microbiology, New York University School of Medicine, New York, New York, United States of America"
        ]
    }
}